Simon Padbury

Simon Padbury
Strategy and Marketing Planner, REPROCELL

Recent Posts

Press Release: ROSLINCT and REPROCELL awarded £1.2 million from Innovate UK for clinical-grade stem cell production

[fa icon="calendar'] Oct 10, 2018 6:35:50 AM / by Simon Padbury posted in Press Release, Research & Development, iPSCs, Stem Cells, Clinical Grade

[fa icon="comment"] 0 Comments

Funding will be used to improve efficiency of induced pluripotent stem cell production

Location: REPROCELL Europe Ltd. (Glasgow, UK) and  RosslinCT (Edinburgh, UK)
Date: October 10, 2018
Continue reading [fa icon="long-arrow-right"]

REPROCELL’s Dr David Bunton on April 2018 Trade Mission to China with Scottish First Minister Nicola Sturgeon

[fa icon="calendar'] Apr 18, 2018 4:44:17 AM / by Simon Padbury

[fa icon="comment"] 0 Comments

REPROCELL Europe’s CEO, Dr David Bunton, was part of last week's  trade mission to China undertaken by the Scottish First Minister, the Rt. Hon. Nicola Sturgeon MSP.

Continue reading [fa icon="long-arrow-right"]

REPROCELL’s Prof Stefan Przyborski to chair the SMi 2nd Annual Conference on 3D Cell Culture – London UK, 21-22 February 2018

[fa icon="calendar'] Jan 24, 2018 11:08:00 AM / by Simon Padbury posted in 3D Cell Culture, Bio-engineered Tissue Models

[fa icon="comment"] 0 Comments

The SMi Group’s conference on 3D Cell Culture will be held on 21-22 February 2018. The venue is the Copthorne Tara Hotel in Kensington, London, UK.

 Find out more at

REPROCELL Europe’s CSO Professor Stefan Przyborski will chair the first day of the conference.

From the Conference Overview:

Building on the sell-out success of the launch event, SMi Group is delighted to announce the return of 3D Cell Culture, taking place on 21st and 22nd of February 2018, in London UK.
Whilst still in its infancy, 3D Cell Culture is rapidly growing with not only a widespread reach that can be seen across a number of different fields such as 3D bioprinting and microfluidics, but also with incredible potential for industrial application. The 2nd annual conference will explore these overlapping areas and will also update delegates on pioneering developments in surrounding topics such as disease models, organoids, organ-on-a-chip technologies and iPSC advances.
Continue reading [fa icon="long-arrow-right"]

Formation of human tissue to improve drug testing and reduce animal research

[fa icon="calendar'] Jan 19, 2018 9:30:56 AM / by Simon Padbury posted in Human Tissues, Bio-engineered Tissue Models, Drug Discovery, 3D Cell Culture

[fa icon="comment"] 0 Comments

REPROCELL’s Alvetex, a scaffold for 3D cell culture and bioengineered tissue models, is in the Durham University (UK) News yesterday, at

Developed at the university by Professor Stefan Prsyborski, Alvetex was first commercialised by the spin-out company Reinnervate – based at NETPark in County Durham, UK. Reinnervate was acquired by REPROCELL Inc. (Japan) in 2014.

Stefan Przyborski is Professor of Cell Technology at Durham University’s Department of Biosciences and Chief Scientific Officer of REPROCELL Europe Ltd.

Continue reading [fa icon="long-arrow-right"]